Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222033 · ClinicalTrials.gov registry record · NA
Self-balancing Personal Exoskeleton for SCI (WINY)
A NA study of Spinal Cord Injury and Paraplegia and Tetraplegia, sponsored by Wandercraft.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07222033: Recruiting NA study of Spinal Cord Injury and Paraplegia and Tetraplegia, sponsored by Wandercraft.
NCT07222033 is a NA study of Spinal Cord Injury and Paraplegia and Tetraplegia that is actively recruiting participants, run by Wandercraft. The registered enrollment target is 12 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222033, a NA study of Spinal Cord Injury and Paraplegia and Tetraplegia, is actively recruiting participants, sponsored by Wandercraft.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Primary Outcome
Collection and analysis of adverse events to evaluate the safety of the device for its intended use and user population, specifically for individuals with spinal cord injury (SCI) performing ambulatory activities hands-free, accompanied by a companion.
Conditions Studied
Interventions
- DEVICE Hands-free exoskeleton
Study Locations (1)
New York
- Walk in New York (WINY) Physical Therapy, P.C. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07222033 shows while recruiting
NCT07222033 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Hands-free exoskeleton is the first listed.
NCT07222033 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07222033 about?
NCT07222033 is a clinical study titled "Self-balancing Personal Exoskeleton for SCI (WINY)". This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
What is the current status of trial NCT07222033?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-08-11. Estimated completion is 2026-05-31.
What conditions does trial NCT07222033 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Paraplegia and Tetraplegia.
What interventions are being tested in trial NCT07222033?
The interventions under investigation include: Hands-free exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT07222033?
This trial is sponsored by Wandercraft, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222033 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07222033's enrollment target sits among peer trials
12 73rd of 99 higher than 21 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI